Form 4: Oscar Health Director Laura Lang Granted Over 14,000 Restricted Stock Units
Insider Transaction Report
Oscar Health, Inc. Director Laura W. Lang was granted 14,134 Class A Common Stock Restricted Stock Units (RSUs) on June 4, 2025, increasing her beneficial ownership to 74,365 shares.
Summary
- Oscar Health, Inc. (OSCR) Director Laura W. Lang acquired 14,134 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) on June 4, 2025.
- The RSUs were granted at a price of $0.00 per share, indicating a compensation grant rather than a purchase.
- Following this transaction, Ms. Lang's direct beneficial ownership of Oscar Health Class A Common Stock increased to 74,365 shares.
- Each RSU represents a contingent right to receive one share of Oscar Health Class A common stock upon vesting.
- The RSUs are subject to vesting on the earlier of the one-year anniversary of the grant date (June 4, 2026) or the date of the next annual meeting of stockholders following the grant date, contingent on continued service.
- Settlement of vested RSUs will occur on the earliest of six months after separation from service, death, or disability, or within five days following a change in control of the Issuer.
Sentiment
Score: 6
Explanation: The document reports a standard RSU grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. There are no negative financial implications or operational issues reported.
Positives
- The grant of 14,134 Restricted Stock Units to Director Laura W. Lang aligns her interests with long-term shareholder value, as the value of the RSUs is tied to the company's stock performance.
- The vesting schedule, contingent on continued service, incentivizes Ms. Lang's ongoing commitment and contribution to Oscar Health.
Future Outlook
The vesting and settlement terms of the RSUs indicate a future commitment from the director, with vesting contingent on continued service and settlement tied to future events such as separation from service or a change in control.
Industry Context
This RSU grant is a standard form of equity compensation for directors in publicly traded companies, particularly in the healthcare technology and insurance sectors, aiming to align director incentives with long-term company performance and shareholder interests.
Comparison to Industry Standards
- The grant of Restricted Stock Units (RSUs) to directors is a common practice across various industries, including healthcare and technology, as a form of non-cash compensation.
- Companies like UnitedHealth Group (UNH), Anthem (now Elevance Health ELV), and Cigna (CI) also utilize equity-based compensation plans for their executives and directors to foster long-term alignment.
- The specific vesting schedule (one-year anniversary or next annual meeting) is typical for director grants, ensuring continued engagement.
- The settlement terms tied to separation or change of control are also standard provisions in such equity agreements.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | Grant of Restricted Stock Units (RSUs) to a director as part of the company's equity compensation plan, aligning director incentives with shareholder interests. | 2025-06-04 | Strengthens alignment between director and shareholder interests, promoting long-term value creation. |
| Power of Attorney | Laura Lang granted power of attorney to specific individuals (R. Scott Blackley, Ranmali Bopitiya, Melissa Curtin) to prepare and file SEC forms on her behalf, streamlining compliance with reporting obligations. | 2022-11-16 | Enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions. |
Related Party Transactions
- The grant of Restricted Stock Units to Laura W. Lang, a director of Oscar Health, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders if the stock price increases.
- Employees: No direct impact on employees mentioned in this filing.
- Management: The grant is part of the overall compensation structure for key personnel, including directors, which can help retain experienced leadership.
Next Steps
- Continued service of Laura W. Lang as a Director of Oscar Health, Inc. until the RSU vesting date.
- Vesting of the 14,134 RSUs on the earlier of June 4, 2026, or the date of the next annual meeting of stockholders following the grant date.
- Settlement of vested RSUs into Class A common stock upon specific future events, such as separation from service or a change in control.
Key Dates
| Date | Description |
|---|---|
| 2022-11-16 | Date Power of Attorney was executed by Laura Lang. |
| 2025-06-04 | Date of RSU grant transaction to Laura W. Lang. |
| 2025-06-06 | Date the Form 4 was signed by Attorney-in-Fact Melissa Curtin. |
| 2026-06-04 | One-year anniversary of the RSU grant date, a potential vesting date. |
Keywords
Oscar Health, OSCR, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Beneficial Ownership, Equity Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.